On December 27, 2018, Cannell Capital LLC — a hedge fund based in Alta, Wyoming – disclosed sending three separate letters to three company managements, notifying them of Cannell’s activist intentions. Buying the stocks targeted by Cannell on that date would have produced an average gain of 32.40% over the 25 trading days since.
Billionaire Mori Arkin filed a 13D on Aclaris Therapeutics (ACRS), a development stage microcap biotech company with a promising treatment for common warts. Arkin bought the shares through his personal partnership, "The 1999 Company." In the activist filing he disclosed the following trades: Purchase/SaleSharesPriceDate Running ...
In a 13G filed Friday evening, Citadel Advisors disclosed a 19.9% Avianca Holdings (AVH) stake. Ken Griffin's hedge fund reported that it owns 82,364,111 preferred shares of AVH issued to Citadel in exchange for a $356 million investment in Avianca. To...
Starboard Value 13Ds are worth paying attention to. The hedge fund, led by manager Jeff Smith, is one of the most prolific -- and successful -- activist funds. Since 2011, Starboard has filed 305 activist reports: 47 initial 13Ds and 258 13D/A SEC...
Leading health care-focused hedge fund Perceptive Advisors increased its Neptune Wellness (NEPT) stake by 37%, buying 5,000,000 shares. The fund made the disclosure via a 13G/A "passive" filing yesterday. Perceptive's purchase comes days after the Quebec-based cannabis extraction company announced a new partnership that will pay Neptune...
Activist Cannell Capital raised its stake in Lee Enterprises (LEE) to 7.37%. The hedge fund filed a 13D/A on July 30 disclosing a 1.7 million additional share purchase of the newspaper publisher. Cannell is now LEE's largest shareholder. Lee Enterprises owns 49...
I'm “done with fossil fuels." That's what Jim Cramer just said on CNBC's Squawk Box. Cramer compared fossil fuel companies to the stigmatized tobacco companies, saying oil stocks are in the “death knell phase.” But if that's true, I wonder why billionaire oil tycoon and hotelier Bob...
Whale Rock filed a 13G on cloud software company Datadog Inc. (DDOG) on Nov. 1, disclosing a new 1.88 million share position. The $61 million stake represents 6.81% of DDOG's outstanding shares. We recently profiled Whale Rock Capital, noting that the fund's returns, based...
Engine Capital filed a 13D on Cymabay (CBAY) two weeks after the development stage biotech company halted a trial of its leading drug candidate causing it's shares to fall as much as 75%. In a 13D filing Thursday evening, New York-based Engine Capital, L.P....
On March 4, Marathon Partners called ELF Beauty "undervalued" in a 13D filing with the SEC. The New York City-based hedge fund disclosed a 5.2% stake, and said in the filing it has "engaged, and plans to continue to engage, with the Issuer’s management and Board of...